Fact of the matter is you're right, he probably doesn't know when they will be up-listed but it seems per your conversations with him that they have done everything they need to do. I'm a patient man and will add more if the stock price goes lower.
This is still a very good company even minus the Up-list and Blood Monitor. As long as they continue to increase revenue and profit, I'm in on this stock.
My hope is that they can purchase a company and or HGM product in the near future. That would add to the bottom line and definitely get the stock price moving.
News 
Market Data 
Discover 
